Investors & Media

Press Releases

View all press releases »

Ionis to present at upcoming investor conferences

November 10, 2022 at 7:05 AM EST

CARLSBAD, Calif., Nov. 10, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

  • Guggenheim 4th Annual Immunology and Neurology Day on Monday, November 14, 2022
  • Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022
  • 5th Annual Evercore ISI HealthCONx on Tuesday, November 29, 2022
  • Piper Sandler 34th Annual Healthcare Conference on Tuesday, November 29, 2022
  • Nasdaq 47th Investor Conference on Wednesday, December 7, 2022
  • BMO 2022 Growth & ESG Conference on Wednesday, December 7, 2022

A live webcast and additional information about each presentation can be accessed on the Investors & Media section of the Ionis website at Replays will be available on the Ionis website within 48 hours of each event.

About Ionis Pharmaceuticals
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company.

To learn more about Ionis, visit and follow us on Twitter @ionispharma


Cision View original content to download multimedia:

SOURCE Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals Investor Contact: 760-603-2331 or Ionis Pharmaceuticals Media Contact: 760-603-4679